← Open Payments lookup

BINGTAO LIN: Open Payments

NPI 1407277155 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$675 in 16 payments from 9 companies in 2025. Trend: 2023 $1,697 · 2024 $760 · 2025 $675

Food & beverage: $675
CompanyPaymentsAmount
ABBVIE INC.4$182
Novo Nordisk Inc2$140
Abbott Laboratories1$114
Bayer Healthcare Pharmaceuticals Inc.3$101
VERTEX PHARMACEUTICALS INCORPORATED2$51
Lilly USA, LLC1$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
Ardelyx, Inc.1$21
Cranial Technologies, Inc1$15

Products named: UBRELVY, Ozempic, PROCLAIM, Kerendia, JOURNAVX, MOUNJARO, RELISTOR, LINZESS.

Industry payments across CA — which companies pay providers there.